4/A

FORM 4/A SUBMISSION

Company: Xenon Pharmaceuticals Inc.
Filed: March 8, 2022
Period of Report: March 4, 2022
Accession Number: 0001209191-22-017418

View Document ↗ View on SEC.gov ↗